We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

146 hedge funds and large institutions have $563M invested in Tvardi Therapeutics in 2018 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 50 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

96% more call options, than puts

Call options by funds: $20.7M | Put options by funds: $10.6M

94% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 17

85% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 27

56% more capital invested

Capital invested by funds: $360M → $563M (+$203M)

12% more funds holding

Funds holding: 130 → 146 (+16)

0.03% more ownership

Funds ownership: 1.63% → 1.66% (+0.03%)

Holders
146
Holders Change
+16
Holders Change %
+12.31%
% of All Funds
3.34%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
33
Increased
50
Reduced
27
Closed
17
Calls
$20.7M
Puts
$10.6M
Net Calls
+$10.1M
Net Calls Change
+$7.92M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$39M
2
BlackRock
BlackRock
New York
+$10.4M
3
State Street
State Street
Massachusetts
+$8.23M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$6.12M
5
NC
Nexthera Capital
New York
+$6.05M

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$3.58M
2
JP Morgan Chase
JP Morgan Chase
New York
-$3.57M
3
CG
Carmignac Gestion
France
-$2.08M
4
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$2.06M
5
CCMW
Cypress Capital Management (Wyoming)
Wyoming
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
OM
26
Opaleye Management
Massachusetts
$3.11M +$2.61M +3,611 New
LPL Financial
27
LPL Financial
California
$2.91M -$17.3K -24 -0.7%
DCM
28
DAFNA Capital Management
California
$2.7M +$1M +1,389 +80%
Wells Fargo
29
Wells Fargo
California
$2.68M +$464K +642 +26%
Allianz Asset Management
30
Allianz Asset Management
Germany
$2.57M +$185K +256 +9%
Federated Hermes
31
Federated Hermes
Pennsylvania
$2.24M +$1.87M +2,590 +51,800%
Citigroup
32
Citigroup
New York
$2.18M +$1.53M +2,113 +515%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$2.05M -$152K -211 -8%
Ameriprise
34
Ameriprise
Minnesota
$2.04M +$1.71M +2,365 New
Morgan Stanley
35
Morgan Stanley
New York
$1.95M +$96.7K +134 +6%
TCIM
36
TIAA CREF Investment Management
New York
$1.68M +$227K +314 +19%
UBS Group
37
UBS Group
Switzerland
$1.55M +$948K +1,313 +274%
EGI
38
EAM Global Investors
California
$1.54M +$1.29M +1,786 New
CWM
39
Cornerstone Wealth Management
Missouri
$1.51M +$125K +173 +44%
TA
40
Teachers Advisors
New York
$1.51M +$170K +235 +15%
Swiss National Bank
41
Swiss National Bank
Switzerland
$1.34M +$168K +233 +18%
SAMH
42
Shanda Asset Management Holdings
British Virgin Islands
$1.32M – – –
HighTower Advisors
43
HighTower Advisors
Illinois
$1.22M +$48.4K +67 +5%
EI
44
EAM Investors
California
$1.22M +$1.02M +1,417 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$1.19M +$167K +231 +20%
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$1.09M +$910K +1,260 New
AllianceBernstein
47
AllianceBernstein
Tennessee
$1.05M -$74.4K -103 -8%
Citadel Advisors
48
Citadel Advisors
Florida
$965K -$747K -1,035 -48%
Wolverine Trading
49
Wolverine Trading
Illinois
$904K +$536K +743 +243%
BRWM
50
B. Riley Wealth Management
Tennessee
$882K +$739K +1,023 New
1
2
3 4 5

TVRD Hedge Fund Activity: Q3 2018 in Review

146 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q3 2018, worth a combined $563M — up 56% from $360M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new TVRD positions and 17 closed out — a net gain of 16 holders — while 50 added to existing stakes and 27 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $39M. The largest seller was Deutsche Bank, cutting an estimated $3.58M.

  • 146 institutional investors held Tvardi Therapeutics (TVRD) as of Q3 2018, up from 130 in Q2 2018.
  • Funds reported $563M of Tvardi Therapeutics stock for Q3 2018, up 56% quarter-over-quarter.
  • 33 funds opened new Tvardi Therapeutics positions in Q3 2018 and 17 closed out, a net change of +16 holders.
  • The largest Tvardi Therapeutics buyer in Q3 2018 was T. Rowe Price Associates, an estimated $39M added.
  • The largest Tvardi Therapeutics seller in Q3 2018 was Deutsche Bank, an estimated $3.58M sold.

Based on aggregated 13F filings for Q3 2018.